Simpson Thacher represented Sterimed in connection with the financing of the investment around its management team, IK Partners, Sagard, and a group of investors brought together in a new structure called “Les Amis de Sterimed”. The transaction closed on May 20, 2025.
Founded in 2016, Sterimed is one of the world’s leading manufacturers of medical sterilization packaging. Sterimed develops, produces, converts and markets various types of ready-to-use packaging solutions for medical device manufacturers, hospitals, pharmaceutical and life sciences industry, and specialized packaging companies. Today, the group benefits from a global footprint with a broad industrial and commercial base.
IK Partners (“IK”) is a European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the U.K. Since 1989, IK has raised more than €19 billion of capital and invested in over 200 European companies. IK supports companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects.
Sagard Mid Cap is a French investment fund that provides equity capital to support the development of mid-sized companies led by ambitious teams. Founded in 2003 with the support of the Desmarais family, Sagard's investors include leading industrial families and top-tier institutional investors. Since its creation, Sagard and its team of 14 professionals based in Paris and Milan have invested in 50 industrial and services companies in France.
The Simpson Thacher team included Hadrien Servais and Eline Souffriau (Banking and Credit).